{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:17:28Z","timestamp":1790979448507,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["3401746"],"award-info":[{"award-number":["3401746"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s13346-025-01794-z","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T12:33:02Z","timestamp":1737721982000},"page":"3137-3148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Colon delivery of agomelatine nanoparticles in the treatment of TNBS induced ulcerative colitis"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3587-9277","authenticated-orcid":false,"given":"Parinaz","family":"Minaiyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9333-5798","authenticated-orcid":false,"given":"Jaleh","family":"Varshosaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2129-6299","authenticated-orcid":false,"given":"Mohsen","family":"Minaiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"1794_CR1","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1056\/NEJMra2002697","volume":"383","author":"JT Chang","year":"2020","unstructured":"Chang JT. Pathophysiology of inflammatory bowel diseases. N Engl J Med. 2020;383:2652\u201364. https:\/\/doi.org\/10.1056\/NEJMra2002697.","journal-title":"N Engl J Med"},{"issue":"11","key":"1794_CR2","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00535-009-0141-8","volume":"44","author":"S Ishihara","year":"2009","unstructured":"Ishihara S, Aziz M, Yuki T, Kazumori H, Kinoshita Y. Inflammatory bowel disease: review from the aspect of genetics. J Gastroenterol. 2009;44(11):1097\u2013108.","journal-title":"J Gastroenterol"},{"key":"1794_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrgastro.2017.136","volume":"15","author":"AN Ananthakrishnan","year":"2018","unstructured":"Ananthakrishnan AN, Bernstein CN, Iliopoulos D, Macpherson A, Neurath MF, Ali RAR, Vavricka SR, Fiocchi C. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol. 2018;15:39\u201349. https:\/\/doi.org\/10.1038\/nrgastro.2017.136.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1794_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/gut.35.3.353","volume":"35","author":"RD Pullan","year":"1994","unstructured":"Pullan RD, Thomas GA, Rhodes M, Newcombe RG, Williams GT, Allen A, Rhodes J. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut. 1994;35:353\u20139. https:\/\/doi.org\/10.1136\/gut.35.3.353.","journal-title":"Gut"},{"issue":"13","key":"1794_CR5","doi-asserted-by":"publisher","first-page":"6966","DOI":"10.3390\/ijms23136966","volume":"23","author":"DA Elhag","year":"2022","unstructured":"Elhag DA, Kumar M, Saadaoui M, Akobeng AK, Al-Mudahka F, Elawad M, Al Khodor S. Inflammatory bowel disease treatments and predictive biomarkers of therapeutic response. Int J Mol Sci. 2022;23(13):6966. https:\/\/doi.org\/10.3390\/ijms23136966.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1794_CR6","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.3390\/nu14122469","volume":"14","author":"M Radziszewska","year":"2022","unstructured":"Radziszewska M, Smarkusz-Zarzecka J, Ostrowska L, Pogodzi\u0144ski D. Nutrition and supplementation in ulcerative colitis. Nutrients. 2022;14(12):2469. https:\/\/doi.org\/10.3390\/nu14122469.","journal-title":"Nutrients"},{"key":"1794_CR7","doi-asserted-by":"publisher","first-page":"765474","DOI":"10.3389\/fmed.2021.765474","volume":"8","author":"Z Cai","year":"2021","unstructured":"Cai Z, Wang S, Li J. Treatment of inflammatory bowel disease: a comprehensive review. Front Med (Lausanne). 2021;8:765474. https:\/\/doi.org\/10.3389\/fmed.2021.765474.","journal-title":"Front Med (Lausanne)"},{"key":"1794_CR8","unstructured":"DeBattista C. Antidepressant drugs. In; Katzung BG, Vanderah TW, editors. 15th edition. Basic and clinical pharmacology. McGraw Hill Company, Lange Medical Books. 2021, pp. 562-5."},{"key":"1794_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1745-0179-2-24","volume":"2","author":"AA Mikocka-Walus","year":"2006","unstructured":"Mikocka-Walus AA, Turnbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. Antidepressants and inflammatory bowel disease: a systematic review. Clin Pract Epidemiol Ment Health. 2006;2:24. https:\/\/doi.org\/10.1186\/1745-0179-2-24.","journal-title":"Clin Pract Epidemiol Ment Health"},{"issue":"8","key":"1794_CR10","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/ibd\/izaa349","volume":"27","author":"RA Marrie","year":"2021","unstructured":"Marrie RA, Graff LA, Fisk JD, Patten SB, Bernstein CN. The relationship between symptoms of depression and anxiety and Disease Activity in IBD over Time. Inflamm Bowel Dis. 2021;27(8):1285\u201393. https:\/\/doi.org\/10.1093\/ibd\/izaa349. PMID: 33393632; PMCID: PMC8314114.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"1794_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.22037\/ghfbb.v17i1.2850","volume":"17","author":"H Khazraei","year":"2024","unstructured":"Khazraei H, Shamsdin SA. The anti-inflammatory effects of antidepressants on colitis. Gastroenterol Hepatol Bed Bench. 2024;17(1):28\u201336. https:\/\/doi.org\/10.22037\/ghfbb.v17i1.2850.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"12","key":"1794_CR12","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2165\/00023210-200620120-00003","volume":"20","author":"M Zupancic","year":"2006","unstructured":"Zupancic M, Guilleminault C. Agomelatine: a preliminary review of a new antidepressant. CNS Drugs. 2006;20(12):981\u201392. https:\/\/doi.org\/10.2165\/00023210-200620120-00003.","journal-title":"CNS Drugs"},{"issue":"3","key":"1794_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/YIC.0b013e3283311acd","volume":"25","author":"G Racagni","year":"2010","unstructured":"Racagni G, Popoli M. The pharmacological properties of antidepressants. Int Clin Psychopharmacol. 2010;25(3):117\u201331.","journal-title":"Int Clin Psychopharmacol"},{"issue":"30","key":"1794_CR14","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.2174\/1381612819666131119110258","volume":"20","author":"I Brzozowska","year":"2014","unstructured":"Brzozowska I, Strzalka M, Drozdowicz D, Konturek JS, Brzozowski T. Mechanisms of esophageal protection, gastroprotection and ulcer healing by melatonin. Implications for the therapeutic use of melatonin in gastroesophageal reflux disease (GERD) and peptic ulcer disease. Curr Pharm Des. 2014;20(30):4807\u201315.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"1794_CR15","first-page":"2926","volume":"8","author":"AS Mahmoud","year":"2021","unstructured":"Mahmoud AS, El-Motteleb DAM, Mahmoud NM, Othman SSM. Assessment of agomelatine possible protective effect in ulcerative colitis patients; an overview. Eur J Mol Cli Med. 2021;8(3):2926\u201337.","journal-title":"Eur J Mol Cli Med"},{"issue":"5","key":"1794_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2174\/1570159X12999140619122914","volume":"12","author":"M Gahr","year":"2014","unstructured":"Gahr M. Agomelatine in the treatment of major depressive disorder: an assessment of benefits and risks. Curr Neuropharmacol. 2014;12(5):287\u2013398.","journal-title":"Curr Neuropharmacol"},{"issue":"5","key":"1794_CR17","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.nano.2015.02.018","volume":"11","author":"S Hua","year":"2015","unstructured":"Hua S, Marks E, Schneider JJ, Keely S. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Nanomedicine. 2015;11(5):1117\u201332. https:\/\/doi.org\/10.1016\/j.nano.2015.02.018.","journal-title":"Nanomedicine"},{"key":"1794_CR18","doi-asserted-by":"publisher","first-page":"114101","DOI":"10.1016\/j.addr.2021.114101","volume":"181","author":"H Hadji","year":"2022","unstructured":"Hadji H, Bouchemal K. Advances in the treatment of inflammatory bowel disease: focus on polysaccharide nanoparticulate drug delivery systems. Adv Drug Deliv Rev. 2022;181:114101. https:\/\/doi.org\/10.1016\/j.addr.2021.114101.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"1794_CR19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jconrel.2011.01.010","volume":"151","author":"P Aksungur","year":"2011","unstructured":"Aksungur P, Demirbilek M, Denkba\u015f EB, Vandervoort J, Ludwig A, \u00dcnl\u00fc N. Development and characterization of cyclosporine A loaded nanoparticles for ocular drug delivery: cellular toxicity, uptake, and kinetic studies. J Control Release. 2011;151(3):286\u201394.","journal-title":"J Control Release"},{"key":"1794_CR20","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.2147\/IJN.S157566","volume":"13","author":"M Naeem","year":"2018","unstructured":"Naeem M, Bae J, Oshi MA, Kim MS, Moon HR, Lee BL, Im E, Jung Y, Yoo JW. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit\u00ae FS30D\/PLGA nanoparticles ameliorates murine experimental colitis. Int J Nanomed. 2018;13:1225\u201340. https:\/\/doi.org\/10.2147\/IJN.S157566.","journal-title":"Int J Nanomed"},{"issue":"20","key":"1794_CR21","first-page":"41","volume":"8","author":"N Venkata Ratnam","year":"2016","unstructured":"Venkata Ratnam N, Gowri Sankar D, Sindhu P, TejaDer T. Pharmacia development and validation of UV spectrophotometric method for estimation of agomelatine in bulk and pharmaceutical dosage form. Der Pharmacia Lettre. 2016;8(20):41\u20136.","journal-title":"Der Pharmacia Lettre"},{"key":"1794_CR22","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.2147\/IJN.S81715","volume":"10","author":"S Sun","year":"2015","unstructured":"Sun S, Liang N, Yamamoto H, Kawashima Y, Cui F, Yan P. pH-sensitive poly(lactide-co-glycolide) nanoparticle composite microcapsules for oral delivery of insulin. Int J Nanomed. 2015;10:3489\u201398.","journal-title":"Int J Nanomed"},{"key":"1794_CR23","doi-asserted-by":"publisher","first-page":"905191","DOI":"10.1155\/2012\/905191","volume":"2012","author":"J Varshosaz","year":"2012","unstructured":"Varshosaz J, Emami J, Tavakoli N, Minaiyan M, Rahmani N, Dorkoosh F. Development and evaluation of a novel pellet-based tablet system for potential colon delivery of budesonide. J Drug Deliv. 2012;2012:905191. https:\/\/doi.org\/10.1155\/2012\/905191.","journal-title":"J Drug Deliv"},{"issue":"3","key":"1794_CR24","first-page":"733","volume":"11","author":"J Varshosaz","year":"2012","unstructured":"Varshosaz J, Emami J, Tavakoli N, Minaiyan M, Rahmani N, Dorkoosh F, Mahzouni P. Pectin film coated pellets for colon-targeted delivery of budesonide: in-vitro\/in-vivo evaluation in induced ulcerative colitis in rat. Iran J Pharm Res. 2012;11(3):733\u201345.","journal-title":"Iran J Pharm Res"},{"key":"1794_CR25","unstructured":"Mahmoud AS, El-Motteleb DMA, Mahmoud NM, Mahmoud SS. Protective effect of agomelatine against acetic acid-induced ulcerative colitis in male albino rats. Annals R S C B 25;(6):13323\u201343."},{"key":"1794_CR26","first-page":"30","volume":"11","author":"A Motavallian-Naeini","year":"2012","unstructured":"Motavallian-Naeini A, Minaiyan M, Rabbani M, Mahzuni P. Antiinflammatory effect of ondansetron through 5-HT3 receptors on TNBS-induced colitis in rat. Excli J. 2012;11:30\u201344.","journal-title":"Excli J"},{"issue":"3","key":"1794_CR27","first-page":"159","volume":"7","author":"A Motavallian-Naeini","year":"2012","unstructured":"Motavallian-Naeini A, Andalib S, Rabbani M, Mahzouni P, Afsharipour M, Minaiyan M. Validation and optimization of experimental colitis induction in rats using 2, 4, 6-trinitrobenzene sulfonic acid. Res Pharm Sci. 2012;7(3):159\u201369.","journal-title":"Res Pharm Sci"},{"issue":"4","key":"1794_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4103\/1319-3767.36750","volume":"13","author":"MA Alzoghaibi","year":"2007","unstructured":"Alzoghaibi MA, Al Mofleh IA, Al-Jebreen AM. Lipid peroxides in patients with inflammatory bowel disease. Saudi J Gastroenterol. 2007;13(4):187\u201390. https:\/\/doi.org\/10.4103\/1319-3767.36750.","journal-title":"Saudi J Gastroenterol"},{"issue":"3","key":"1794_CR29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4103\/RPS.RPS_131_23","volume":"19","author":"M Minaiyan","year":"2024","unstructured":"Minaiyan M, Abolhasani S, Sima S, Yegdaneh A. Effect of Tamarindus indica L. fruit pulp and seed extracts on experimental ulcerative colitis in rats. Res Pharm Sci. 2024;19(3):276\u201386. https:\/\/doi.org\/10.4103\/RPS.RPS_131_23.","journal-title":"Res Pharm Sci"},{"issue":"2","key":"1794_CR30","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3390\/ijms24021526","volume":"24","author":"A Saez","year":"2023","unstructured":"Saez A, Herrero-Fernandez B, Gomez-Bris R, S\u00e1nchez-Martinez H, Gonzalez-Granado JM. Pathophysiology of inflammatory bowel disease: innate immune system. Int J Mol Sci. 2023;24(2):1526.","journal-title":"Int J Mol Sci"},{"issue":"16","key":"1794_CR31","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.3390\/molecules28165979","volume":"28","author":"R Cordiano","year":"2023","unstructured":"Cordiano R, Di Gioacchino M, Mangifesta R, Panzera C, Gangemi S, Minciullo PL. Malondialdehyde as a potential oxidative stress marker for allergy-oriented diseases: an update. Molecules. 2023;28(16):5979.","journal-title":"Molecules"},{"issue":"1","key":"1794_CR32","first-page":"e1004","volume":"9","author":"DR Hansberry","year":"2017","unstructured":"Hansberry DR, Shah K, Agarwal P, Agarwal N. Fecal myeloperoxidase as a biomarker for inflammatory bowel disease. Cureus. 2017;9(1):e1004.","journal-title":"Cureus"},{"issue":"5","key":"1794_CR33","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/0016-5085(92)91710-L","volume":"102","author":"Y Yamada","year":"1992","unstructured":"Yamada Y, Marshall S, Specian RD, Grisham MB. A comparative analysis of two models of colitis in rats. Gastroenterology. 1992;102(5):1524\u201334.","journal-title":"Gastroenterology"},{"issue":"1","key":"1794_CR34","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1021\/acs.molpharmaceut.2c00558","volume":"20","author":"RK Mishra","year":"2023","unstructured":"Mishra RK, Ahmad A, Kanika, Kumar A, Vyawahare A, Sakla R, Nadeem A, Siddiqui N, Raza SS, Khan R. Caffeic acid-conjugated budesonide-loaded Nanomicelle attenuates inflammation in experimental colitis. Mol Pharm. 2023;20(1):172\u201382. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00558. Epub 2022 Dec 6. PMID: 36472567.","journal-title":"Mol Pharm"},{"key":"1794_CR35","doi-asserted-by":"publisher","first-page":"111582","DOI":"10.1016\/j.msec.2020.111582","volume":"119","author":"A Ahmad","year":"2021","unstructured":"Ahmad A, Ansari MM, Mishra RK, Kumar A, Vyawahare A, Verma RK, Raza SS, Khan R. Enteric-coated gelatin nanoparticles mediated oral delivery of 5-aminosalicylic acid alleviates severity of DSS-induced ulcerative colitis. Mater Sci Eng C Mater Biol Appl. 2021;119:111582. https:\/\/doi.org\/10.1016\/j.msec.2020.111582. Epub 2020 Oct 6. PMID: 33321628.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"1794_CR36","doi-asserted-by":"publisher","first-page":"112038","DOI":"10.1016\/j.msec.2021.112038","volume":"124","author":"JM Soni","year":"2021","unstructured":"Soni JM, Sardoiwala MN, Choudhury SR, Sharma SS, Karmakar S. Melatonin-loaded chitosan nanoparticles endows nitric oxide synthase 2 mediated anti-inflammatory activity in inflammatory bowel disease model. Mater Sci Eng. 2021;124:112038.","journal-title":"Mater Sci Eng"},{"issue":"34","key":"1794_CR37","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.3748\/wjg.v17.i34.3888","volume":"17","author":"CQ Chen","year":"2011","unstructured":"Chen CQ, Fichna J, Bashashati M, Li YY, Storr M. Distribution, function and physiological role of melatonin in the lower gut. World J Gastroenterol. 2011;17(34):3888\u201398.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"1794_CR38","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1023\/A:1020107915919","volume":"47","author":"GA Bubenik","year":"2002","unstructured":"Bubenik GA. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci. 2002;47(10):2336\u201348.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"1794_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000109491","volume":"2","author":"PP Lee","year":"1993","unstructured":"Lee PP, Pang SF. Melatonin and its receptors in the gastrointestinal tract. Biol Signals. 1993;2(4):181\u201393.","journal-title":"Biol Signals"},{"issue":"2","key":"1794_CR40","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/diagnostics13020204","volume":"13","author":"R Vaccaro","year":"2023","unstructured":"Vaccaro R, Casini A, Severi C, Lamazza A, Pronio A, Palma R. Serotonin and melatonin in human lower gastrointestinal tract. Diagnostics (Basel). 2023;13(2):204.","journal-title":"Diagnostics (Basel)"},{"key":"1794_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.archoralbio.2017.05.015","volume":"82","author":"JY Hyeon","year":"2017","unstructured":"Hyeon JY, Choi EY, Choe SH, Park HR, Choi JI, Choi IS, Kim SJ. Agomelatine, a MT1\/MT2 melatonergic receptor agonist with serotonin 5-HT2C receptor antagonistic properties, suppresses Prevotella intermedia lipopolysaccharide-induced production of proinflammatory mediators in murine macrophages. Arch Oral Biol. 2017;82:11\u20138.","journal-title":"Arch Oral Biol"},{"issue":"Pt A","key":"1794_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.neuropharm.2016.08.006","volume":"110","author":"I Salzer","year":"2016","unstructured":"Salzer I, Gantumur E, Yousuf A, Boehm S. Control of sensory neuron excitability by serotonin involves 5HT2C receptors and ca(2+)-activated chloride channels. Neuropharmacology. 2016;110(Pt A):277\u201386.","journal-title":"Neuropharmacology"},{"key":"1794_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1745-0179-2-24","volume":"2","author":"AA Mikocka-Walus","year":"2006","unstructured":"Mikocka-Walus AA, Turnbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. Antidepressants and inflammatory bowel disease: a systematic review. Clin Pract Epidemiol Ment Health. 2006;2:24.","journal-title":"Clin Pract Epidemiol Ment Health"},{"key":"1794_CR44","doi-asserted-by":"publisher","unstructured":"Kristensen MS, Kj\u00e6rulff TM, Ersb\u00f8ll AK, Green A, Hallas J, Thygesen LC. The influence of antidepressants on the disease course among patients with crohn\u2019s disease and ulcerative colitis-a Danish nationwide register-based cohort study. Inflamm Bowel Dis. 2019;25(5):886\u2013893. https:\/\/doi.org\/10.1093\/ibd\/izy367. Erratum in: Inflamm Bowel Dis. 2019;25(11):e152.","DOI":"10.1093\/ibd\/izy367"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01794-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01794-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01794-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T03:56:32Z","timestamp":1757130992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01794-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1794"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01794-z","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"8 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Isfahan University of Medical Sciences (approved at 2023, coded IR.MUI.ACE.1401.055).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This research doesn\u2019t involve human subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This research doesn\u2019t involve human subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}